AG
Ashu Gaur
About Ashu Gaur
Data last updated:
Ashu Gaur is a Director at Aspkom Eixil Consulting Private Limited (since 2018) and Director at Aarogena Farmaceuticals Private Limited (since 2025). The companies operate in Business Services and Agriculture. The largest current company by reported revenue is Aspkom Eixil Consulting Private Limited at ₹1.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aspkom Eixil Consulting Private Limited U74999DL2018PTC332357 | Director | 11 Apr 2018 | 2018 | ₹1.7 Lakh (FY 2025) | Active |
| Aarogena Farmaceuticals Private Limited U32509UP2025PTC225704 | Director | 09 Jun 2025 | 2025 | Active |
Board colleagues of Ashu Gaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shikha Mathur | 11338556 | Aspkom Eixil Consulting Private Limited | Director |
| Deeksha Agrawal | 11145357 | Aarogena Farmaceuticals Private Limited | Director |
| Rajat Agrawal | 06834012 | Aarogena Farmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashu Gaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashu Gaur
Ashu Gaur currently holds 2 directorships: Aspkom Eixil Consulting Private Limited (Director, since 11 Apr 2018, revenue ₹1.7 Lakh (FY 2025)); Aarogena Farmaceuticals Private Limited (Director, since 09 Jun 2025).
Ashu Gaur was first appointed on 11 Apr 2018 as Director at Aspkom Eixil Consulting Private Limited. The most recent appointment on record is 09 Jun 2025 at Aarogena Farmaceuticals Private Limited.
The current boards of Ashu Gaur's companies include Shikha Mathur (Aspkom Eixil Consulting Private Limited), Deeksha Agrawal (Aarogena Farmaceuticals Private Limited), Rajat Agrawal (Aarogena Farmaceuticals Private Limited).